EDGAR Filing Documents for 0001737287-24-000033

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001737287-24-000033

Filing Date

2024-04-23

Accepted

2024-04-23 16:32:34

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	allo-20240423xdefa14axnoti.htm	DEFA14A	12437
2		allogenetherapeuticsinc_vx.jpg	GRAPHIC	3783103
3		allogenetherapeuticsinc_vxa.jpg	GRAPHIC	4330028
	Complete submission text file	0001737287-24-000033.txt		11171591

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080

Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700

Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38693 | Film No.: 24865263
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)